Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
about
Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumoursPharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulationZoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration.Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection statusAuranofin is a potent suppressor of osteosarcoma metastasis.Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcomaDownregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine OsteosarcomaDysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.Bone microenvironment signals in osteosarcoma development.RETRACTED: Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma.Epigenetic regulation of bone cells.Drugs in early clinical development for the treatment of osteosarcoma.Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.Bone sarcomas: from biology to targeted therapies.A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Biology of Bone Sarcomas and New Therapeutic Developments.Identification of Key Gene Modules in Human Osteosarcoma by Co-Expression Analysis Weighted Gene Co-Expression Network Analysis (WGCNA).RANKL blockade prevents and treats aggressive osteosarcomas.Identification of key gene modules for human osteosarcoma by co-expression analysis.IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
P2860
Q26852760-FB7706CE-AA43-42A1-BB8C-7742C66A2E68Q33276145-FF120CC2-3795-4443-88DA-D2E50F5E0A6EQ33882079-33444217-9E83-437F-BFEA-5A9266E71C06Q34599958-26864CD0-17D3-4AC0-8DF2-6A4A58420EA7Q35115510-AEF130EB-7A76-4729-8FBD-F97D193C93C7Q35758432-4EE8203E-BC0B-4BBB-B31A-578CD8D317C4Q36661456-E2937DD4-4CBB-4A06-BE2E-C1701BB30CB7Q36729542-1BCA25AC-8631-4C3C-8A7F-50AF573CCDCCQ37125088-EE8F9AA2-B550-45F2-803B-09D8445BCD0AQ37384979-50D4B264-7EB8-45F4-A92E-8D446A4C7023Q37694632-D0926DAA-59BA-4F26-BB47-811E3F6E5E47Q38454980-2CE14F42-66EA-4E6F-A1A4-B86EA7CAF9A9Q38482145-7D539494-5552-43A5-89A7-558EFAC336E0Q38880734-3927C3B1-14F0-4B7F-83A7-55F982E5EED4Q38955517-9542992C-978E-4785-908D-91D2546B3D51Q39032864-5C11F6C6-EDD9-4F6B-8F46-EBF73D7858A9Q39647944-D7BAE19F-ACB3-4E7C-A824-7985523681A2Q41126812-B772FD24-44DC-4247-9E15-D61656C40332Q41923624-4BDF18F3-F529-494B-A6BA-59601BB071D6Q42280200-5FF0D6C6-BC2B-480A-97E9-96A522DB7CCFQ42632659-0367684A-7987-47C7-B4CB-A22D879A2901Q42634367-85D2058A-1818-402B-AED2-3F0A2E9180E3Q48120956-24931C67-F876-42C6-834E-84FCB73F9D4EQ48290693-3B8998BA-726C-4A15-9078-EF02BB2549D8Q54228752-1A6565ED-5F15-4480-8393-E31F683D5BDDQ55313513-7E48C8D7-B0BA-4A57-8024-798AF996C69AQ58710862-457C3174-E339-4773-A0E9-C0E8116395DA
P2860
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@en
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@nl
type
label
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@en
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@nl
prefLabel
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@en
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
@nl
P2093
P50
P1433
P1476
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases
@en
P2093
Alexander Guminski
Andreas Evdokiou
Andrew Cumming
Claudia Cueva
Danielle Wilson
Danny Rickwood
Geoffrey Strutton
Ian Dickinson
Scott Sommerville
P304
P356
10.1158/0008-5472.CAN-09-4291
P407
P577
2010-09-07T00:00:00Z